Animal models for muscular dystrophy show different patterns of sarcolemmal disruption

Journal of Cell Biology

Volumn 139, Issue 2, 1997, Pages 375-385

  Straub, Volker ^a   Rafael, Jill A ^b   Chamberlain, Jeffrey S ^b   Campbell, Kevin P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; DYSTROPHIN; EVANS BLUE; GLYCOPROTEIN; LAMININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; GENE MUTATION; MOUSE; MUSCLE CONTRACTION; MUSCLE INJURY; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; SARCOLEMMA; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; DYSTROPHIN; EVANS BLUE; HUMANS; MICE; MICE, INBRED MDX; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; MUTAGENESIS; MUTATION; MYOCARDIUM; SARCOLEMMA; SERUM ALBUMIN;

EID: 0030783172     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.139.2.375     Document Type: Article

References (59)

1. Allamand, V., Y. Sunada, M.A.M. Salih, V. Straub, C.O. Ozo, M.H.S. AlTuraike, M. Akbar, T. Kolo, H. Collognato, X. Zhang, et al. 1997. Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain. Hum. Mol. Genet. 6:747-752.
2. Bell, C.D., and P.E. Conen. 1968. Histopathological changes in Duchenne muscular dystrophy. J. Neurol. Sci. 7:529-544.
3. Bodensteiner, J.B., and A.G. Engel. 1978. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology. 28:439-446.
4. Bradley, W.G., and J.J. Fulthorpe. 1978. Studies of sarcolemmal integrity in myopathic muscle. Neurology. 28:670-677.
5. Bulfield, G., W.G. Siller, P.A. Wight, and K.J. Moore. 1984. X chromosomelinked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA. 81:1189-1192.
6. Carpenter, S., and G. Karpati. 1979. Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain. 102: 147-161.
7. Clarke, M.S., R.W. Caldwell, H. Chiao, K. Miyake, and P.L. McNeil. 1995. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ. Res. 76:927-934.
8. Corrado, K., J.A. Rafael, P.L. Mills, N.M. Cole. J.A. Faulkner, K. Wang, and J.S. Chamberlain. 1996. Transgenic mdx mice expressing dystrophin with a deletion in the actin-binding domain display a "mild Becker" phenotype. J. Cell Biol. 134:873-884.
9. Cox, G.A., Y. Sunada, K.P. Campbell, and J.S. Chamberlain. 1994. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle fails to prevent dystrophy. Nature Genet. 8:333-339.
10. D'Amore, P.A., R.H. Brown, Jr., P.T. Ku, E.P. Hoffman, H. Watanabe, K. Arahata, T. Ishihara, and J. Folkman. 1994. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy Ann. Neurol. 35:362-365.
11. Dhermy, D. 1991. The spectrin super-family. Biol. Cell. 71:249-254.
12. Dubowitz, V. 1985. Muscle Biopsy: A practical approach. Bailliere Tindall Ltd., London. 720 pp.
13. England, S.B., L.V. Nicholson. M.A. Johnson, S.M. Forrest, D.R. Love, E.E. Zubrzycka-Gaarn, D.E. Bulman, J.B. Harris, and K.E. Davies. 1990. Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (Lond.). 343:180-182.
14. Ervasti, J.M., K. Ohlendieck, S.D. Kahl, M.G. Gaver, and K.P. Campbell. 1990. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature (Lond.). 345:315-319.
15. Ervasti, J.M., and K.P. Campbell. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122:809-823.
16. Gillis, J.M. 1996. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol. Scand. 156:397-406.
17. Greenberg, D.S., Y. Sunada, K.P. Campbell, D. Yaffe, and U. Nudel. 1994. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nature Genet. 8:340-344.
18. Head, S.I., D.A. Williams, and D.G. Stephenson. 1992. Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice. Proc. R. Soc. Lond. B. Biol. Sci. 248:163-169.
19. Helbling-Leclerc, A., H. Topaloglu, F.M. Tome, C. Sewry, G. Gyapay, I. Naom, F. Muntoni, V. Dubowitz, A. Barois, B. Estournet, et al., 1995. Readjusting the localization of merosin (laminin alpha 2-chain) deficient congenital muscular dystrophy locus on chromosome 6q2. C. R. Acad. Sci. III. 318:1245-1252.
20. Henry, M.D., and K.P. Campbell. 1996. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr. Opin. Cell Biol. 8:625-631.
21. Hoffman, E.P., R.H. Brown, Jr., and L.M. Kunkel. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:919-928.
22. Jung, D., B. Yang, J. Meyer, J.S. Chamberlain, and K.P. Campbell. 1995. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J. Biol. Chem. 270:27305-27310.
23. Karpati, G., and S. Carpenter. 1982. Micropuncture lesions of skeletal muscle cells: a new experimental model for the study of muscle cell damage, repair and regeneration. In Disorders of the Motor Unit. D. L. Schotland, editor. John Wiley, New York. 517.
24. Kaye, D., D. Pimental, S. Prasad, T. Maki, H.J. Berger, P.L. McNeil, T.W. Smith, and R. A. Kelly. 1996. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J. Clin. Invest. 97:281-291.
25. Koenig, M., A.P. Monaco, and L.M. Kunkel. 1988. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 53:219-226.
26. Matsuda, R., A. Nishikawa, and H. Tanaka. 1995. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. (Tokyo). 118:959-964.
27. McNeil, P.L., L. Muthukrishnan, E. Warder, and P.A. D'Amore. 1989. Growth factors are released by mechanically wounded endothelial cells. J. Cell Biol. 109:811-822.
28. McNeil, P.L., and R. Khakee. 1992. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am. J. Pathol. 140:1097-1109.
29. Minetti, C., M. Bado, G. Morreale, M. Pedemonte, and G. Cordone. 1996. Disruption of muscle basal lamina in congenital muscular dystrophy with merosin deficiency. Neurology. 46:1354-1358.
30. Mokri, B., and A.G. Engel. 1975. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology. 25:1111-1120.
31. Muthukrishnan, L., E. Warder, and P.L. McNeil. 1991. Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells. J. Cell Physiol. 148:1-16.
32. Nissinen, M., A. Helbling-Leclerc, X. Zhang, T. Evangelista, H. Topaloglu, C. Cruaud, J. Weissenbach, M. Fardeau, F. M. Tome, K. Schwanz, et al. 1996. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am. J. Hum. Genet. 58:1177-1184.
33. Ohlendieck, K., J.M. Ervasti, K. Matsumura, S.D. Kahl, C.J. Leveille, and K.P. Campbell. 1991a. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron. 7:499-508.
34. Ohlendieck, K., J.M. Ervasti, J.B. Snook, and K.P. Campbell. 1991b. Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J. Cell Biol. 112:135-148.
35. Ohlendieck, K., and K.P. Campbell. 1991a. Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle. FEBS Lett. 283:230-234.
36. Ohlendieck, K., and K.P. Campbell. 1991b. Dystrophin-associaled proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol. 115:1685-1694.
37. Ozawa, E., M. Yoshida, A. Suzuki, Y. Mizuno, Y. Hagiwara, and S. Noguchi. 1995. Dystrophin-associated proteins in muscular dystrophy. Hum. Mol. Genet. 4(Spec. No.):1711-1716.
38. Pasternak, C., S. Wong, and E.L. Elson. 1995. Mechanical function of dystrophin in muscle cells. J. Cell Biol. 128:355-361.
39. Petrof, B.J., J.B. Shrager, H.H. Stedman, A.M. Kelly, and H.L. Sweeney. 1993. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl. Acad. Sci. USA. 90:3710-3714.
40. Phelps, S.F., M.A. Hauser, N.M. Cole, J.A. Rafael, R.T. Hinkle, J.A. Faulkner, and J.S. Chamberlain. 1995. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice. Hum. Mol. Genet. 4:1251-1258.
41. Porter, G.A., G.M. Dmytrenko, J.C. Winkelmann, and R.J. Bloch. 1992. Dystrophin colocalizes with beta-spectrin in distinct subsarcolemmal domains in mammalian skeletal muscle. J. Cell Biol. 117:997-1005.
42. Rafael, J.A., Y. Sunada, N.M. Cole, K.P. Campbell, J.A. Faulkner, and J.S. Chamberlain. 1994. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform. Hum. Mol. Genet. 3:1725-1733.
43. Rafael, J.A., G.A. Cox, K. Corrado, D. Jung, K.P. Campbell, and J.S. Chamberlain. 1996. Forced expression of dyslrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134:93-102.
44. 131-labeled proteins to measurements of blood volume. Ann. NY Acad. Sci. 70:137.
45. Rosalki, S.B. 1989. Serum enzymes in disease of skeletal muscle. Clin. Lab. Med. 9:767-781.
46. Rybakova, I.N., K.J. Amann, and J.M. Ervasti. 1996. A new model for the interaction of dystrophin with F-actin. J. Cell Biol. 135:661-672.
47. Schittny, J.C., and P.D. Yurchenco. 1990. Terminal short arm domains of basement membrane laminin are critical for its self-assembly. J. Cell Biol. 110: 825-832.
48. Schmalbruch, H. 1975. Segmental fibre breakdown and defects of the plasmalemma in diseased human muscles. Acta Neuropathol. (Berlin). 33:129-141.
49. Schmalbruch, H. 1984. Regenerated muscle fibers in Duchenne muscular dystrophy: a serial section study. Neurology. 34:60-65.
50. Straub, V., R.E. Bittner, J.J. Leger, and T. Voit. 1992. Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J. Cell Biol. 119: 1183-1191.
51. Straub, V., and K.P. Campbell. 1997. Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10:168-175.
52. Sunada, Y., S.M. Bernier, C.A. Kozak, Y. Yamada, and K.P. Campbell. 1994. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J. Biol. Chem. 269:13729-13732.
53. Sunada, Y., S.M. Bernier, A. Utani, Y. Yamada, and K.P. Campbell. 1995. Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum. Mol. Genet. 4:1055-1061.
54. Suzuki, A., M. Yoshida, K. Hayashi, Y. Mizuno, Y. Hagiwara, and E. Ozawa. 1994. Molecular organization at the glycoprotein-complex-binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur. J. Biochem. 220:283-292.
55. Tidball, J.G. 1991. Force transmission across muscle cell membranes. J. Biomech. 24(Suppl. 1):43-52.
56. Tomé, F.M., T. Evangelista, A. Leclerc, Y. Sunada, E. Manole, B. Estournet, A. Barois, K.P. Campbell, and M. Fardeau. 1994. Congenital muscular dystrophy with merosin deficiency. C. R. Acad. Sci. III. 317:351-357.
57. Weller, B., G. Karpati, and S. Carpenter. 1990. Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci. 100:9-13.
58. Xu, H., P. Christmas, X.R. Wu, U.M. Wewer, and E. Engvall. 1994a. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc. Natl. Acad. Sci. USA. 91:5572-5576.
59. Xu, H., X.R. Wu, U.M. Wewer, and E. Engvall. 1994b. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat. Genet. 8:297-302.